Navigation Links
Alzheimer's drug developer lands $1.2M in venture funding

Madison, Wis. - Mithridion, Inc., a biopharmaceutical start up that is developing drugs to disrupt the progress of Alzheimer's disease, has closed an additional $1.2 million of Series A funding led by Madison's Venture Investors.

The latest round of funding brings the total equity capital raised in th......

Full article >>> s, and the continued support of WARF and Rosetta Partners.

"It's a great leap forward for our company in getting Venture Investors, a professional investment firm," Twose said. "It's not only a leap forward in terms of getting the funding, it's the quality of the investors they bring in."

The new funding will be used to advance Mithridion's drug lead, a prototype drug that will b......

Full article >>> ts discovery is based on animal models used in Alzheimer's research. "It was noted that they [the animals] did not develop the full form of Alzheimer's, which caused investors to ask why?" Neis said.

......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 04/17/07


Related biology technology :

1. Biotech firm has strokes, Alzheimers in its sights
2. Mithridion wins grants for Alzheimers research
3. Alzheimers drug firm and more winners named in Wisconsin business-plan contest
4. Alzheimers drug market to hit $5.5 billion by 2009, study says
5. Marshfield study mixes DNA into electronic medical record to screen for Alzheimers
6. UW Alzheimers researchers found company; privacy law; Science Expeditions
7. Madison-based Mithridion seeks to capitalize on Alzheimers breakthrough
8. Discovery may halt progression of Alzheimers
9. Milwaukee software developer gains bottom line, loses waistline
10. Emerging game developer begins work on prototypes
11. Metavante to buy California software developer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/9/2017)...  BioTech Holdings announced today identification and patenting ... stem cell therapy prevents limb loss in animal ... that treatment with ProCell resulted in more than ... to standard bone marrow stem cell administration.  Interestingly, ... of therapeutic effect.  ...
(Date:10/9/2017)... ... October 09, 2017 , ... At its national board meeting in North ... in Harvard University’s Departments of Physics and Astronomy, has been selected for membership in ... winning team for the 2015 Breakthrough Prize in Fundamental physics for the discovery of ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... October 5, 2017, in the medical journal, Epilepsia, Brain Sentinel’s SPEAC® System ... standard, video EEG, in detecting generalized tonic-clonic seizures (GTCS) using surface electromyography ...
(Date:10/7/2017)... ... October 06, 2017 , ... Phase ... metagenome deconvolution product, featuring the first commercially available Hi-C kit. Researchers can ... Hi-C metagenome deconvolution using their own facilities, supplementing the company’s full-service ProxiMeta ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 Research and Markets has announced ... report to their offering. ... global eye tracking market to grow at a CAGR of 30.37% ... Tracking Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
(Date:3/30/2017)... 2017 The research team of The Hong ... fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery and ... speed and accuracy for use in identification, crime investigation, immigration control, ... ... A research team led ...
Breaking Biology News(10 mins):